Compare CVS Health Corp (CVS) vs LyondellBasell Industries NV (LYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs LyondellBasell Industries NV — how do they compare? CVS Health Corp trades at $104.75 (market cap $135.48B), while LyondellBasell Industries NV trades at $58.5 (market cap $18.90B). The key difference: CVS Health Corp is far larger — about 7.2× LyondellBasell Industries NV's market cap, and LyondellBasell Industries NV pays the higher dividend (7.04%). Which is the better fit depends on your goals.
| CVS | LYB | |
|---|---|---|
Market Cap | $135.48B | $18.90B |
Sector | Health | Basic Materials |
52-Week High | $106.18 | $82.38 |
52-Week Low | $58.75 | $42.28 |
Enterprise Value | $202.02B | $30.52B |
Dividend Yield | 2.51% | 7.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
LyondellBasell (LYB) trades at $58.32, up 3.49% today, with a bullish technical signal supported by moving averages and ADX indicators. The company reported mixed earnings, beating estimates in Q1 2026 but missing in Q4 2025, while revenue has declined from $50.5B in 2022 to $30.2B in 2025. Recent news highlights partnerships for sustainable packaging and upcoming Q2 2026 results. Despite negative net income margins and ROE, LYB maintains positive operating cash flow and a dividend payout.
LYB presents a cautious opportunity with analyst consensus leaning toward Buy (43.59%) and a $73.11 price target, suggesting 25% upside. Risks include persistent revenue declines, elevated debt, and industry headwinds, but cost-cutting and focus on high-margin polymers offer potential recovery. Investors should weigh the bullish technicals and analyst optimism against fundamental challenges in the chemical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →
